跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GANIRELIX-AFT SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 0.25 MG/0.5 ML - HSA Drug Approval Details
Approvals
/
HSA
/
GANIRELIX-AFT SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 0.25 MG/0.5 ML
Approved
THERAPEUTIC
GANIRELIX-AFT SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 0.25 MG/0.5 ML
Qilu Pharmaceutical Co., Ltd. (CHINA)
🇸🇬 Health Sciences Authority
Approval Date
Jun 11, 2026
Approval ID
9b271ef52469ef50
Company
Qilu Pharmaceutical Co., Ltd. (CHINA)
Type
Therapeutic
Approval Details
Approval Id
9b271ef52469ef50
Drug Name
GANIRELIX-AFT SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 0.25 MG/0.5 ML
Product Name
GANIRELIX-AFT SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 0.25 MG/0.5 ML
Approval Number
SIN17558P
Approval Date
2026-06-11
Registrant
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION
Route Of Administration
SUBCUTANEOUS
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 11, 2026
Approval ID
9b271ef52469ef50
Type
Therapeutic
Back to HSA Approvals